Identifying early postoperative serum parathyroid hormone levels as predictors of hypocalcaemia after total thyroidectomy: A prospective non-randomized study

2020 ◽  
Vol 41 (3) ◽  
pp. 102416
Author(s):  
Andro Košec ◽  
Filip Hergešić ◽  
Filip Matovinović ◽  
Ivan Rašić ◽  
Davor Vagić ◽  
...  
Nephron ◽  
1991 ◽  
Vol 59 (2) ◽  
pp. 333-333
Author(s):  
Nurol Arik ◽  
Turgay Arinsoy ◽  
Murat Sayin ◽  
Ilgar Taşdemir ◽  
Ünal Yasavul ◽  
...  

2014 ◽  
Vol 80 (8) ◽  
pp. 817-820 ◽  
Author(s):  
Amy E. Rivere ◽  
Ashton J. Brooks ◽  
Genevieve A. Hayek ◽  
Heng Wang ◽  
Ralph L. Corsetti ◽  
...  

We hypothesized that parathyroid hormone (PTH) determination would be the most effective strategy to identify posttotal thyroidectomy hypoparathyroidism (PTTHP) compared with other clinical and laboratory parameters. We retrospectively reviewed our recent experience with total thyroidectomy. We recorded demographics, malignancy, thyroid weight, parathyroid autotransplantation, hospital stay, use of postoperative calcium and hormonally active vitamin D3 (calcitriol), and postoperative serum calcium and PTH levels. Patients were divided into two groups depending on whether supplemental calcitriol was required to maintain eucalcemia and therefore reflecting the diagnosis of PTTHP. From October 2010 to June 2013, a total of 202 total thyroidectomies were performed. Twenty-four patients (12%) developed PTTHP and required calcitriol replacement. Logistic regression analysis revealed that only postoperative calcium levels ( P = 0.02) and PTH levels ( P < 0.0001) statistically significantly predicted PTTHP. Twenty-two of 29 patients with PTH 13 pg/mL or less had PTTHP. Only two of 173 patients with a PTH level greater than 13 pg/mL were diagnosed with PTTHP. We recommend using PTH levels after total thyroidectomy to determine which patients will have hypoparathyroidism requiring calcitriol therapy. An early determination of PTTHP allows for prompt management that can shorten hospital stay and improve outcomes.


1972 ◽  
Vol 35 (2) ◽  
pp. 213-218 ◽  
Author(s):  
MORDECAI M. POPOVTZER ◽  
WULF F. PINGGERA ◽  
MARTIN P. HUTT ◽  
JOHN ROBINETTE ◽  
CHARLES G. HALGRIMSON ◽  
...  

1993 ◽  
Vol 7 (4) ◽  
pp. 378-378 ◽  
Author(s):  
Cynthia T. McMurtry ◽  
Francine W. Schranck ◽  
Denise A. Walkenhorst ◽  
William A. Murphy ◽  
David B. Kocher ◽  
...  

2017 ◽  
Vol 131 (10) ◽  
pp. 925-929 ◽  
Author(s):  
M Erlem ◽  
N Klopp-Dutote ◽  
A Biet-Hornstein ◽  
V Strunski ◽  
C Page

AbstractObjective:To determine whether pre-operative serum 25-hydroxyvitamin D has an impact on post-operative parathyroid hormone and serum calcium levels in patients undergoing total thyroidectomy for benign goitre.Methods:This single-centre, retrospective study comprised 246 unselected surgical patients who had undergone total thyroidectomy for bilateral, benign, multinodular goitre. The correlation between pre-operative serum 25-hydroxyvitamin D and post-operative serum parathyroid hormone and serum calcium was studied to determine whether low pre-operative serum 25-hydroxyvitamin D was predictive of post-operative hypocalcaemia.Results:Seventy-nine patients (32 per cent) had post-operative hypocalcaemia. Eighteen patients (7.32 per cent) experienced unintentional parathyroidectomy (1 parathyroid gland in 15 patients, 2 parathyroid glands in 3 patients). In univariate analysis, pre-operative serum 25-hydroxyvitamin D was not correlated with post-operative serum calcium (p = 0.69) or post-operative serum parathyroid hormone (p = 0.5804). Furthermore, in multivariate analysis, which took into account unintentional parathyroidectomy, no correlation was found (p = 0.33). Bilateral unintentional parathyroidectomy was statistically associated with post-operative hypocalcaemia (p = 0.032).Conclusion:Pre-operative serum 25-hydroxyvitamin D did not appear to have any impact on post-operative serum calcium in patients undergoing total thyroidectomy for benign goitre.


Sign in / Sign up

Export Citation Format

Share Document